Form 4: Amphastar Pharmaceuticals Director Floyd F. Petersen Sells 3,000 Shares

Sentiment:

SEC Form 4 Filing


Director Floyd F. Petersen of Amphastar Pharmaceuticals sold 3,000 shares of common stock at a weighted average price of $46.4724 on September 5, 2024.

Summary

  • On September 5, 2024, Floyd F. Petersen, a director of Amphastar Pharmaceuticals, Inc., sold 3,000 shares of the company's common stock.
  • The sale was executed at a weighted average price of $46.4724 per share.
  • Following the transaction, Petersen directly owns 75,409 shares of Amphastar Pharmaceuticals' common stock.
  • The reporting person has undertaken to provide full information regarding the number of shares sold at each separate price upon request.

Sentiment

Score: 5

Explanation: This is a neutral event. A director selling shares doesn't necessarily indicate a negative outlook, as it could be for personal financial reasons. It's a routine disclosure.

Industry Context

This Form 4 filing is a routine disclosure of a transaction by a company insider. It provides transparency to the market regarding the trading activities of individuals with access to non-public information.

Stakeholder Impact

  • The sale of shares by a director could have a minor impact on shareholder confidence, but is unlikely to be significant given the relatively small number of shares involved.

Key Dates

DateDescription
09/05/2024Date of transaction: Floyd F. Petersen sold 3,000 shares of Amphastar Pharmaceuticals' common stock.
09/06/2024Date of signature on the Form 4 filing.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.